LivaNova Shares Rise After Outlook Boost

Dow Jones
May 06
 

By Connor Hart

 

Shares of LivaNova climbed after the medical-technology company raised its outlook for the year.

The stock rose 17% to $67.17 on Wednesday, extending its more than 54% run over the past year.

LivaNova now expects full-year revenue to increase 7% to 8%, up from previous guidance for 6%-to-7% growth. It also raised its outlook for adjusted per-share earnings to between $4.20 and $4.30 from its prior range of $4.15 to $4.25.

The higher outlook came after first-quarter results were higher than anticipated. Adjusted earnings came in at 98 cents a share, ahead of the 91 cents a share that analysts polled by FactSet were looking for.

Revenue grew 14% to $362.3 million and topped Wall Street models for $345.7 million.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

May 06, 2026 10:53 ET (14:53 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10